Patent information
IP India · live recordApplication number
202547041387
Filing date
29 April 2025
Status
Under Examination
Publication number
21/2025
Publication type
INA
Invention field
Biotechnology
Abstract
The present invention relates to a stable GLP-2 peptide injectable composition, comprising GLP-2 peptide agent comprises of sodium; wherein the GLP-2 peptide agent is teduglutide or h[Gly2]GLP-2 and one or more pharmaceutically acceptable excipient(s).
Applicants
1India
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
P. No. 53,
ALEAP Industrial Estate,
Pragati Nagar, Kukatpally,
Hyderabad-500 090,
Telangana
Inventors
3India
VALLABHBHAI, Patel BhaveshkumarOrbicular Pharmaceutical
Technologies Pvt. Ltd.
P. No. 53, ALEAP Industrial Estate,
Pragati Nagar, Kukatpally,
Hyderabad-500 090,
Telangana
India
KANNEKANTI, RaghuOrbicular Pharmaceutical
Technologies Pvt. Ltd.
P. No. 53, ALEAP Industrial Estate,
Pragati Nagar, Kukatpally,
Hyderabad-500 090
Telangana
India
NIPPANI, Anjali DeviOrbicular Pharmaceutical
Technologies Pvt. Ltd.
P. No. 53, ALEAP Industrial Estate,
Pragati Nagar, Kukatpally,
Hyderabad-500 090,
Telangana
Documents
Sign in to openApplication documents
1
202547041387-REQUEST FOR EXAMINATION (FORM-18) [29-04-2025(online)].pdf
29 Apr 2025
2
202547041387-POWER OF AUTHORITY [29-04-2025(online)].pdf
29 Apr 2025
3
202547041387-FORM 18 [29-04-2025(online)].pdf
29 Apr 2025
4
202547041387-FORM 1 [29-04-2025(online)].pdf
29 Apr 2025
5
202547041387-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2025(online)].pdf
29 Apr 2025
6
202547041387-COMPLETE SPECIFICATION [29-04-2025(online)].pdf
29 Apr 2025